Redirection of cellular immunity by protein tyrosine kinase chimeras
    1.
    发明授权
    Redirection of cellular immunity by protein tyrosine kinase chimeras 失效
    蛋白酪氨酸激酶嵌合体细胞免疫的重定向

    公开(公告)号:US6004811A

    公开(公告)日:1999-12-21

    申请号:US394912

    申请日:1995-02-24

    摘要: Disclosed is a method of directing a cellular response in a mammal by expressing in a cell of the mammal a chimeric receptor which causes the cells to specifically recognize and destroy an infective agent, a cell infected with an infective agent, a tumor or cancerous cell, or an autoimmune-generated cell. The chimeric receptor includes an extracellular portion which is capable of specifically recognizing and binding the target cell or target infective agent, and (b) an intracellular portion of a protein-tyrosine kinase which is capable of signalling the therapeutic cell to destroy a receptor-bound target cell or a receptor-bound target infective agent. Also disclosed are calls which express the chimeric receptors and DNA encoding the chimeric receptors.

    摘要翻译: 公开了一种通过在哺乳动物细胞中表达嵌合受体来引导细胞反应的方法,所述嵌合受体导致细胞特异性识别和破坏感染剂,感染了感染剂,肿瘤或癌细胞的细胞, 或自身免疫产生的细胞。 嵌合受体包括能够特异性识别和结合靶细胞或靶感染剂的细胞外部分,和(b)蛋白质 - 酪氨酸激酶的细胞内部分,其能够表达治疗细胞以破坏受体结合 靶细胞或受体结合的靶感染剂。 还公开了表达嵌合受体和编码嵌合受体的DNA的调用。